Time to Invest in L...
Health Care: Drugs
Trubion Pharmaceuticals Inc. (TRBN: NASDAQ)
$4.60 0.06 | 1.32%
10/28/10 - 03:59 PM ET
Ratio Comparisons
Financial Ratios data is not available for TRBN.
Portfolios with TRBN
- Portfolio NameUser Type
- UserASCO 2009 Nymph's Watch List.
- Userstickytrade Portfolio 1
- Userolympicwinebrokers Portfolio 1
Latest TRBN Headlines from TheStreet
- Trubion, ShoreTel: Volume Movers 08.13.10 | 07:08 am
- AtriCure, RAM Energy: Volume Movers 06.15.10 | 07:06 am
- RCM Technologies, Navarre: Early Volume Plays 06.04.10 | 08:06 am
- Biogen Idec Offers $356.1M For Facet Biotech 09.04.09 | 01:09 pm
- Trubion Licenses Drug To Facet In $196.5M Deal 08.28.09 | 10:08 am
- Health Winners & Losers: Biovail 06.20.08 | 04:06 pm
- Tuesday's Health Winners & Losers 09.11.07 | 04:09 pm
- Trubion Edges Higher 10.18.06 | 03:10 pm
Press Releases for TRBN
- Levi & Korsinsky, LLP Announces Class Action Lawsuit Against Trubion Pharmaceuticals, Inc. And Its Board Of Directors - Business Wire 10.05.10 | 11:10 am
- Law Office Of Abe Shainberg Announces Investigation Of Possible Breach Of Fiduciary Duty By The Board Of Trubion Pharmaceuticals Inc. In Connection With Sale To Emergent BioSolutions Inc. - TRBN - Business Wire 08.17.10 | 04:08 pm
- Bull & Lifshitz, LLP Announces Investigation Of The Acquisition Of Trubion Pharmaceuticals, Inc. - Business Wire 08.16.10 | 01:08 pm
- The Law Office Of Vincent Wong Announces Investigation Of Possible Breach Of Fiduciary Duty By The Board Of Trubion Pharmaceuticals Inc. - TRBN - Business Wire 08.16.10 | 11:08 am
- Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Shareholders Of Trubion Pharmaceuticals, Inc. - Business Wire 08.13.10 | 08:08 pm
- Ryan & Maniskas, LLP Announces Investigation Of Trubion Pharmaceuticals, Inc. - Business Wire 08.13.10 | 04:08 pm
- Kendall Law Group Investigates Trubion Pharmaceuticals, Inc. Acquisition For Shareholders - Business Wire 08.13.10 | 04:08 pm
- The Briscoe Law Firm, PLLC And Cash Powers Taylor, LLP Announce The Investigation Of Possible Breaches Of Fiduciary Duties Concerning The Acquisition Of Trubion Pharmaceuticals, Inc. - Business Wire 08.13.10 | 12:08 pm
- The Law Office Of Joseph Klein Announces Investigation Of Possible Breach Of Fiduciary Duty By The Board Of Trubion Pharmaceuticals Inc. - TRBN - Business Wire 08.13.10 | 12:08 pm
- Robbins Umeda LLP Announces An Investigation Of The Acquisition Of Trubion Pharmaceuticals, Inc. By Emergent Biosolutions Inc. - Business Wire 08.12.10 | 11:08 pm
Partner Headlines for TRBN
- Biotech's Slow Week Gets Stirred by a Few Smaller Deals - Seeking Alpha 08.15.10 | 04:08 am
- Big Setback for Trubion - Analyst Blog - Zacks 06.17.10 | 06:06 pm
- Trubion Loss Wider Than Expected - Analyst Blog - Zacks 03.22.10 | 04:03 pm
